Interleukin-37 Mediates the Antitumor Activity in Hepatocellular Carcinoma: Role for CD57+ NK Cells

Human NK Cells: From Surface Receptors to the Therapy of Leukemias and Solid Tumors

(2014) Lorenzo Moretta et al.   Frontiers in Immunology

Immunotherapeutic Approach for Better Management of Cancer - Role of IL-18

(2013) Manohar Babu Kuppala et al.   Asian Pacific Journal of Cancer Prevention

Associations Between Infiltrating Lymphocyte Subsets and Hepatocellular Carcinoma

(2013) Cun-Li Guo et al.   Asian Pacific Journal of Cancer Prevention

The Critical Role of the Tumor Microenvironment in Shaping Natural Killer Cell-Mediated Anti-Tumor Immunity

(2013) Joanna Baginska et al.   Frontiers in Immunology

Tumor Protection by IL-7 Secreting Whole Cell Vaccine is Merely Mediated by NK1.1-positive Cells

(2012) Caroline Schroten et al.   JOURNAL OF IMMUNOTHERAPY

Trial watch

(2012) Laura Senovilla et al.   OncoImmunology

Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3

(2011) Runqiu Jiang et al.   HEPATOLOGY

Identification of LZAP as a New Candidate Tumor Suppressor in Hepatocellular Carcinoma

(2011) Jing-jing Zhao et al.   PLoS One

Interleukin 37 expression protects mice from colitis

(2011) E. N. McNamee et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

In Vivo Expression of Interleukin-37 Reduces Local and Systemic Inflammation in Concanavalin A-Induced Hepatitis

(2011) Ana-Maria Bulau et al.   TheScientificWorldJOURNAL

IL-37 is a fundamental inhibitor of innate immunity

(2010) Marcel F Nold et al.   NATURE IMMUNOLOGY

The tumor microenvironment in hepatocellular carcinoma: Current status and therapeutic targets

(2010) Ju Dong Yang et al.   SEMINARS IN CANCER BIOLOGY

High serum interleukin-6 level predicts future hepatocellular carcinoma development in patients with chronic hepatitis B

(2009) Vincent Wai-Sun Wong et al.   INTERNATIONAL JOURNAL OF CANCER

Serum IL-6 levels and the risk for hepatocarcinogenesis in chronic hepatitis C patients: An analysis based on gender differences

(2009) Hayato Nakagawa et al.   INTERNATIONAL JOURNAL OF CANCER

Efficacy, Safety, and Potential Biomarkers of Sunitinib Monotherapy in Advanced Hepatocellular Carcinoma: A Phase II Study

(2009) Andrew X. Zhu et al.   JOURNAL OF CLINICAL ONCOLOGY

Inflammatory tumour microenvironment is associated with superior survival in hepatocellular carcinoma patients

(2009) Valerie Chew et al.   JOURNAL OF HEPATOLOGY

Expression of interleukins-23 and 27 leads to successful gene therapy of hepatocellular carcinoma

(2009) Peng Hu et al.   MOLECULAR IMMUNOLOGY